Copenhagen Oe

• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/ … Not authorised
  2022-500410-26-00 5 Cystic Fibrosis
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into … Not authorised
  2022-501644-15-00 4 Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 1 Advanced solid tumors
• Boosting recovery through excitation of arousal and awareness in comatose patients (BREA2KTHROUGH) Not authorised
  2023-503617-30-01 9 Coma and other disorders of consciousness due to acute traumatic and n
• [68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic canc … Not authorised
  2023-503632-41-00 4 Pancreatic cancer and gastroesophageal cancer (esophagus, gastroesopha
• Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation Not authorised
  2023-504159-29-00 4 Hyperglycaemia after renal transplantation
• LIGHTBEAM-U01 Substudy 01B: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Pembrolizumab in Combination with Investigational Ag … Not authorised
  2023-507179-23-00 9 Hematologic Malignancies or Solid Tumors in Pediatric and Young Adults
• Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised
  2024-516074-29-00 5 Cardiac arrest
• A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Not authorised
  2024-519862-33-00 1 Platinum-resistant ovarian cancer (PROC)
• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 5 Focal cerebral arteriopathy and childhood stroke Focal cerebral arteri
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• Adding oxygen to enhance antibiotic treatment of chronic lung infection Pending
  2024-513197-22-02 3 Primary ciliary dyskinesia
• A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R … Pending
  2024-513445-37-00 5 previously untreated RT, irrespective of risk factors and disease stag
• A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and imm … Pending
  2024-515627-10-00 7 generalised myasthenia gravis
• STRATIFY II Pending
  2024-515712-45-00 6 Pulmonary embolism
• Use of Isoprenaline with Epinephrine During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Pending
  2024-516074-29-01 5 Cardiac arrest
• BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending
  2024-516115-24-00 9 High risk relapsed neuroblastoma (relapsed or progressed after being d
• A Randomized Clinical Trial Investigating Olaparib, Durvalumab (MEDI4736) and UV1 as Maintenance Therapy in BRCAwt Patients with Recurrent O … Pending
  2024-516327-14-00 4 Ovarian cancer
• Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE) Pending
  2024-516896-34-00 9 progressive/relapsed/refractory pediatric low-grade glioma (pLGG)
• Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending
  2024-517133-40-00 5 newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC ampli
• Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe … Pending
  2024-518420-80-00 5 Primary infection prophylaxis for secondary immunodeficiency (SID) in
• Stabilization of vulnerable atherosclerotic carotid plaques by Rivaroxaban as evaluated by 3D contrast enhanced ultrasound (CEUS) Pending
  2024-518539-13-00 11 Patients with - Stable peripheral artery disease and - Asymptomatic, a
• Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease Pending
  2024-518640-20-00 4 Chronic ischemic heart disease
• TRALULALA-AZI Pending
  2024-518730-88-00 6 Chronic Atelectasis

Showing 1–24 of 671 trials